NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …
Read More »Phase 3 Trial of Genentech’s Tecentriq Plus Chemo as Initial Treatment for Patients with Early Triple-Negative Breast Cancer Meets Primary Endpoint
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »